Diagnostic sensitivities of an epilepsy management smartphone application and remotely-reported EEG in newly-presenting epilepsy in the Democratic Republic of Congo
Prince Kazadi , Steve Coates , Najib Kissani , Victor Patterson
{"title":"Diagnostic sensitivities of an epilepsy management smartphone application and remotely-reported EEG in newly-presenting epilepsy in the Democratic Republic of Congo","authors":"Prince Kazadi , Steve Coates , Najib Kissani , Victor Patterson","doi":"10.1016/j.yebeh.2025.110521","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and Objectives</h3><div>To compare the sensitivities of a smartphone application (Epilepsy Management Aid, [EMA]), and remotely-reported EEG, in diagnosing epilepsy in newly-presenting patients in the Democratic Republic of Congo (DRC).</div></div><div><h3>Methods</h3><div>Consecutive patients seen by five community doctors were studied. All had their history recorded using the EMA, the summary of which was messaged to a specialist who replied with advice, and all had an EEG performed and reported remotely. As the reference standard, a convenience sample was seen by videoconsultation by an epilepsy specialist, who determined whether patients had epilepsy or not. Sensitivities of both tests were compared with the reference standard using McNemar’s test.</div></div><div><h3>Results</h3><div>Sixty-one patients with both app result and EEG were studied, of whom 21 were seen by videoconsultation. All patients seen had epilepsy. Sensitivity for the EMA was 95.2 % (95 % confidence intervals 74.1, 99.7), and for the EEG 19 % (95 % confidence intervals 6.3, 42.6). Sensitivities were significantly different with a p value of <0.0001.</div></div><div><h3>Discussion</h3><div>The 95 % accuracy of the EMA suggests that it should be useful to empower doctors in low-resource settings to manage epilepsy, thus improving access for patients and reducing the epilepsy treatment gap. The system is potentially both generalisable and scalable.</div></div>","PeriodicalId":11847,"journal":{"name":"Epilepsy & Behavior","volume":"172 ","pages":"Article 110521"},"PeriodicalIF":2.3000,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epilepsy & Behavior","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1525505025002616","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BEHAVIORAL SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Background and Objectives
To compare the sensitivities of a smartphone application (Epilepsy Management Aid, [EMA]), and remotely-reported EEG, in diagnosing epilepsy in newly-presenting patients in the Democratic Republic of Congo (DRC).
Methods
Consecutive patients seen by five community doctors were studied. All had their history recorded using the EMA, the summary of which was messaged to a specialist who replied with advice, and all had an EEG performed and reported remotely. As the reference standard, a convenience sample was seen by videoconsultation by an epilepsy specialist, who determined whether patients had epilepsy or not. Sensitivities of both tests were compared with the reference standard using McNemar’s test.
Results
Sixty-one patients with both app result and EEG were studied, of whom 21 were seen by videoconsultation. All patients seen had epilepsy. Sensitivity for the EMA was 95.2 % (95 % confidence intervals 74.1, 99.7), and for the EEG 19 % (95 % confidence intervals 6.3, 42.6). Sensitivities were significantly different with a p value of <0.0001.
Discussion
The 95 % accuracy of the EMA suggests that it should be useful to empower doctors in low-resource settings to manage epilepsy, thus improving access for patients and reducing the epilepsy treatment gap. The system is potentially both generalisable and scalable.
期刊介绍:
Epilepsy & Behavior is the fastest-growing international journal uniquely devoted to the rapid dissemination of the most current information available on the behavioral aspects of seizures and epilepsy.
Epilepsy & Behavior presents original peer-reviewed articles based on laboratory and clinical research. Topics are drawn from a variety of fields, including clinical neurology, neurosurgery, neuropsychiatry, neuropsychology, neurophysiology, neuropharmacology, and neuroimaging.
From September 2012 Epilepsy & Behavior stopped accepting Case Reports for publication in the journal. From this date authors who submit to Epilepsy & Behavior will be offered a transfer or asked to resubmit their Case Reports to its new sister journal, Epilepsy & Behavior Case Reports.